CN Stock MarketDetailed Quotes

688687 Beijing Kawin Technology Share-Holding

Watchlist
  • 27.21
  • +0.04+0.15%
Market Closed Oct 31 15:00 CST
4.65BMarket Cap34.62P/E (TTM)

About Beijing Kawin Technology Share-Holding Company

The company was founded in 2008. The company is a high-tech biomedical company with independent innovation and R&D capabilities, focusing on the field of viruses and immune diseases, integrating R&D, production and sales of innovative drugs. It was selected as a “specialized, special and new” small giant enterprise in Beijing and a leapfrog development (G20) engineering enterprise for the biomedical industry in Beijing. The company was officially listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange on February 8, 2021. The company is a high-tech biomedical company with independent innovation and research capabilities, focusing on the field of viruses and immune diseases, integrating R&D, production and sales of innovative drugs. The company's main products are Kailiwei (Clopavir hydrochloride capsules), Cybovir (solifenbuvir tablets), Pai Probiotic (human interferon α2b vaginal effervescent tablets), Kane Probiotics (human interferon α2b injections), Caine Ganlo/Glycyrrhizin (compound glycyrrhizide capsules, compound glycyrrhizide tablets, compound glycyrrhizide injections), and Amboz (pyfenidone tablets). Company Honors: Innovative Pilot Enterprise, Beijing Patent Demonstration Unit, China's Top 100 Pharmaceutical Innovation Enterprises, Ministry of Education's First Prize for Scientific Progress, Top 20 High-tech High-growth Companies, etc.

Company Profile

Short Name-A北京凯因科技
Company NameBeijing Kawin Technology Share-Holding Co., Ltd.
Listing DateFeb 8, 2021
Issue Price18.98
Shares Offered42.46M share(s)
FoundedAug 20, 2008
Chairmandesheng zhou
Legal Representativedesheng zhou
General Managerdesheng zhou
Secretarychongfei he
Employees584
ProvinceBei Jing Shi
Phone010-67892271
Office AddressBuilding 3, No. 6, Rongjing East Street, Beijing Economic and Technological Development Zone, Beijing
Zip Code100176
Registered AddressBuilding 3, No. 6, Rongjing East Street, Beijing Economic and Technological Development Zone, Beijing
Fax010-67892271
Emailir@kawin.com.cn
Business License911103026787533566
BusinessThe issuer is a biomedical company that focuses on the field of viral diseases using biotechnology as a platform and is committed to providing treatment solutions.

Company Executives

  • Name
  • Position
  • Salary
  • desheng zhou
  • Chairman, Directors, General Manager
  • 4.21M
  • jifeng shi
  • Directors, Deputy General Manager, Core Technical Personnel
  • 1.75M
  • shaoping yin
  • Directors
  • --
  • manli sun
  • Independent Directors
  • 144.00K
  • jianwei zhu
  • Independent Directors
  • 144.00K
  • chen du
  • Independent Directors
  • 144.00K
  • chongfei he
  • Board Secretary, Deputy General Manager
  • 1.95M
  • yali zhou
  • Securities Affairs Representative
  • --
  • yin wu
  • Auditors
  • --
  • ye zhang
  • Auditors
  • --
  • zhenqiang du
  • Deputy General Manager
  • 980.00K
  • jian tang
  • Deputy General Manager
  • 2.80M
  • xiao xu
  • Deputy General Manager
  • 1.15M
  • shan liu
  • Core Technical Personnel
  • 730.00K
  • xiang li
  • Core Technical Personnel
  • 550.00K
  • lu yang
  • Core Technical Personnel
  • 870.00K
  • zhan wang
  • Chief Human Resources Officer
  • --
  • tao wang
  • Chief Research Officer
  • 2.68M
  • yan cui
  • Employee Supervisors
  • 360.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data